カテゴリ： MarketsandMarkets, 世界, 医療/バイオ

動物用レファレンスラボラトリーの世界市場予測（～2027）：サービス種類別、用途別、動物別、地域別

■ 英語タイトル：Veterinary Reference Laboratory Market by Service Type (Clinical Chemistry, Immunodiagnostics (ELISA), Molecular Diagnostics (PCR, Microarray)), Application (Pathology, Virology), Animal (Companion, Livestock), and Region - Global Forecast to 2027

調査会社MarketsandMarkets社が発行したリサーチレポート（データ管理コード：MD4362-23）■ 発行会社/調査会社：MarketsandMarkets
■ 商品コード：MD4362-23
■ 発行日：2022年12月20日
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：304
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥1,010,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,238,800見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[動物用レファレンスラボラトリーの世界市場予測（～2027）：サービス種類別、用途別、動物別、地域別]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

MarketsandMarkets社は、世界の動物用レファレンスラボラトリー市場規模が2022年41億ドルから2027年64億ドルに達し、予測期間中に年平均9.3％で成長すると予測しています。本調査資料では、動物用レファレンスラボラトリーの世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、サービス種類別（臨床化学、免疫診断（ELISA）、分子診断、尿検査、その他）分析、用途別（臨床病理学、細菌学、ウイルス学、寄生虫学、生産性試験）分析、動物別（コンパニオンアニマル、家畜）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況、企業情報などの内容を掲載しています。また、本レポートに掲載されている企業情報には、IDEXX Laboratories,Inc. (US)、VCA,Inc. (US)、GD Animal Health (Netherlands)、Zoetis Inc. (US)、NEOGEN Corporation (US)、LABOKLIN GmbH (Germany)、SYNLAB International GmbH (Germany)、Heska Corporation (US)、Virbac (US)、Vaxxinova Gmbh (Netherlands)、Thermo Fisher Scientific,Inc. (US)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の動物用レファレンスラボラトリー市場規模：サービス種類別
- 臨床化学サービスの市場規模
- 免疫診断（ELISA）サービスの市場規模
- 分子診断サービスの市場規模
- 尿検査サービスの市場規模
- その他サービスの市場規模
・世界の動物用レファレンスラボラトリー市場規模：用途別
- 臨床病理学における市場規模
- 細菌学における市場規模
- ウイルス学における市場規模
- 寄生虫学における市場規模
- 生産性試験における市場規模
・世界の動物用レファレンスラボラトリー市場規模：動物別
- コンパニオンアニマルにおける市場規模
- 家畜における市場規模
・世界の動物用レファレンスラボラトリー市場規模：地域別
- 北米の動物用レファレンスラボラトリー市場規模
- ヨーロッパの動物用レファレンスラボラトリー市場規模
- アジア太平洋の動物用レファレンスラボラトリー市場規模
- 中南米の動物用レファレンスラボラトリー市場規模
- 中東・アフリカの動物用レファレンスラボラトリー市場規模
・競争状況
・企業情報

“世界の動物用レファレンスラボラトリー市場は、予測期間中のCAGR 9.3%で、2022年の41億米ドルから2027年には64億米ドルに達すると予測”
予測期間中の動物用レファレンスラボラトリー市場の成長を促進する要因は、動物人口の増加、特にコンパニオンアニマル、多くの人々のペット保険への関心、先進地域の国々の獣医師の数の増加、ミルクとミルク関連乳製品の需要の増加です。

“免疫診断サービス分野が動物用レファレンスラボラトリー市場で第2位のシェアを占める見込み”
免疫診断サービスセグメントは、2021年の動物用レファレンスラボラトリー市場で2番目に大きなシェアを占めています。技術別に見ると、免疫診断サービス分野はさらにELISA、ラテラルフローアッセイ、その他の免疫診断サービスに区分されます。

“臨床病理学セグメントは動物用レファレンスラボラトリー市場で最も高いCAGRで成長する見込み”
用途に基づき、動物用レファレンスラボラトリー市場は臨床病理学、細菌学、寄生虫学、ウイルス学、生産性検査、妊娠検査、毒物学検査に区分されます。臨床病理学セグメントは、2021年の動物用レファレンスラボラトリー市場で最も高いCAGRで成長する見込みです。このセグメントの成長は、主に病理学的検査の実施量の増加が、臨床病理学アプリケーション用の診断製品や消耗品の需要を促進する主な要因によるものです。

“コンパニオンアニマル向け動物用レファレンスラボラトリー市場では犬セグメントが最大シェアを占める見込み”
動物の種類に基づき、コンパニオンアニマル向け動物用レファレンスラボラトリー市場は、犬、猫、馬、その他のコンパニオンアニマルに区分されます。2021年、コンパニオンアニマル向け動物用レファレンスラボラトリー市場において、犬向け市場が最大のシェアを占めています。犬の人獣共通感染症や慢性疾患、寄生虫感染症例の増加により、各種診断サービスの需要が高まっています。

“予測期間中、米国が動物用レファレンスラボラトリー市場を支配”
2021年の北米の動物用レファレンスラボラトリー市場では、米国が最大のシェアを占めています。米国市場の成長は、コンパニオンアニマルの採用増加、ペット保険業界の成長、獣医医療費の上昇、獣医診療所の増加によるものです。また、動物用レファレンスラボラトリー市場の主要企業の大半は米国に拠点を置いています。

本レポートで参照した動物用レファレンスラボラトリー市場の主要参入企業の内訳は以下の通りです：
– 企業タイプ別 ティア1〜60％、ティア2〜30％、ティア3〜10％
– 役職別 Cレベル-30％、ディレクターレベル-50％、その他-20％
– 地域別 北米-45%、欧州-15%、アジア太平洋地域-25%、中南米-10%、中東・アフリカ-5％

動物用レファレンスラボラトリー市場における主なプレーヤーは、IDEXX Laboratories, Inc. (US), VCA, Inc. (US), GD Animal Health (Netherlands), Zoetis Inc. (US), NEOGEN Corporation (US), LABOKLIN GmbH (Germany), SYNLAB International GmbH (Germany), Heska Corporation (US), Virbac (US), Vaxxinova Gmbh (Netherlands), Thermo Fisher Scientific, Inc. (US), Texas A&M Veterinary Medical Diagnostic Laboratory (US), University of Minnesota (Veterinary Diagnostic Laboratory) (US), Iowa State University (Veterinary Diagnostic Laboratory) (US), Vetnostics (Australia), ProtaTek International Inc. (US), Animal and Plant Health Agency (UK), Animal Health Diagnostic Center (Cornell University) (US), National Veterinary Services Laboratory USDA-APHIS (US), Washington Animal Disease Diagnostic Laboratory (US), Colorado State University (Veterinary Diagnostic Laboratories) (US), The Pirbright Institute (UK), GreenCross Limited (Australia), Friedrich-Loeffler-Institute (FLI) (Germany), and Kansas State Veterinary Diagnostic Laboratory (US)などが含まれています。

調査範囲
この調査レポートは、様々な動物用レファレンスラボラトリー市場とその採用パターンを分析しています。世界の動物用レファレンスラボラトリー市場の市場規模や今後の成長性、サービスタイプ、用途、動物タイプ、地域などの異なるセグメントを推定することを目的としています。また、同市場の主要企業の会社概要、製品・サービス内容、最近の動向など、詳細な競合分析も掲載しています。

レポート購入の理由
本レポートは、既存企業だけでなく、新規参入企業や小規模企業にとっても、市場の動向を把握する上で有益であり、ひいては、より大きなシェアを獲得する上で役立ちます。本レポートを購入された企業は、市場での存在感を高めるために、以下の5つの戦略のいずれか、または任意の組み合わせを使用することができます。

本レポートでは、以下のポイントに関する洞察を提供しています：
市場への浸透： 世界の動物用レファレンスラボラトリー市場におけるトップ企業が提供する製品ポートフォリオに関する包括的な情報。
製品開発/イノベーション： 世界の動物用レファレンスラボラトリー市場における今後の動向、研究開発活動、製品またはサービスの発売に関する詳細な洞察。
市場開発： サービスの種類、用途、動物の種類、地域別の有利な新興地域に関する包括的情報。
市場の多様化： 世界の動物用レファレンスラボラトリー市場における新製品、成長地域、最新動向に関する網羅的情報。
競合評価： 世界の動物用レファレンスラボラトリー市場における主要企業の市場シェア、成長戦略、収益分析、製品・サービスに関する詳細な評価。

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 INTRODUCTION 37
1.1 STUDY OBJECTIVES 37
1.2 MARKET DEFINITION 38
1.2.1 INCLUSIONS AND EXCLUSIONS 38
1.3 MARKET SCOPE 38
1.3.1 MARKETS COVERED 39
FIGURE 1 VETERINARY REFERENCE LABORATORY MARKET SEGMENTATION 39
FIGURE 2 VETERINARY REFERENCE LABORATORY MARKET, BY REGION 40
1.4 YEARS CONSIDERED 40
1.5 CURRENCY 41
1.6 STAKEHOLDERS 41
1.7 SUMMARY OF CHANGES 41
2 RESEARCH METHODOLOGY 43
2.1 RESEARCH DATA 43
FIGURE 3 RESEARCH DESIGN 43
2.1.1 SECONDARY DATA 44
2.1.1.1 Key data from secondary sources 45
2.1.2 PRIMARY DATA 45
FIGURE 4 PRIMARY SOURCES 45
2.1.2.1 Key data from primary sources 46
2.1.2.2 Key industry insights 47
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 47
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 48
2.2 MARKET SIZE ESTIMATION 48
FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 49
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES 49
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: VETERINARY REFERENCE LABORATORY MARKET (2021) 50
FIGURE 10 TOP-DOWN APPROACH 51
FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027): IMPACT ON MARKET GROWTH AND CAGR 52
FIGURE 12 CAGR PROJECTIONS 53
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 54
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY 54
2.4 MARKET SHARE ESTIMATION 55
2.5 STUDY ASSUMPTIONS 55
2.6 RISK ASSESSMENT 55
2.7 LIMITATIONS 56
2.7.1 SCOPE-RELATED LIMITATIONS 56
2.7.2 METHODOLOGY-RELATED LIMITATIONS 56
3 EXECUTIVE SUMMARY 57
FIGURE 14 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2022 VS. 2027 (USD MILLION) 57
FIGURE 15 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2022 VS. 2027 (USD MILLION) 58
FIGURE 16 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2022 VS. 2027 (USD MILLION) 59
FIGURE 17 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 60
FIGURE 18 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2022 VS. 2027 (USD MILLION) 60
FIGURE 19 VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2022 VS. 2027 (USD MILLION) 61
FIGURE 20 VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2022 VS. 2027 (USD MILLION) 62
FIGURE 21 GEOGRAPHICAL SNAPSHOT OF VETERINARY REFERENCE LABORATORY MARKET 63
4 PREMIUM INSIGHTS 64
4.1 VETERINARY REFERENCE LABORATORY MARKET OVERVIEW 64
FIGURE 22 GROWTH IN COMPANION ANIMAL POPULATION TO DRIVE MARKET 64
4.2 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE & COUNTRY (2021) 65
FIGURE 23 CLINICAL CHEMISTRY ACCOUNTED FOR LARGEST SHARE OF APAC VETERINARY REFERENCE LABORATORY MARKET IN 2021 65
4.3 VETERINARY REFERENCE LABORATORY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 66
FIGURE 24 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 66
4.4 VETERINARY REFERENCE LABORATORY MARKET: REGIONAL MIX 67
FIGURE 25 NORTH AMERICA TO DOMINATE VETERINARY REFERENCE LABORATORY MARKET DURING FORECAST PERIOD 67
4.5 VETERINARY REFERENCE LABORATORY MARKET: DEVELOPED MARKETS VS. EMERGING MARKETS 67
FIGURE 26 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 67
5 MARKET OVERVIEW 68
5.1 INTRODUCTION 68
5.2 MARKET DYNAMICS 68
FIGURE 27 VETERINARY REFERENCE LABORATORY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 68
5.2.1 DRIVERS 69
5.2.1.1 Growth in companion animal population 69
TABLE 1 PET POPULATION, BY ANIMAL, 2014–2020 (MILLION) 70
5.2.1.2 Rising demand for pet insurance and increasing animal health expenditure 70
TABLE 2 US: AVERAGE PREMIUMS PAID (2019–2021) 70
FIGURE 28 CANADA: AVERAGE ANNUAL PREMIUMS, 2017–2021 71
FIGURE 29 US: PET INDUSTRY EXPENDITURE, 2010–2021 71
TABLE 3 US: BREAKDOWN OF PET INDUSTRY EXPENDITURE, 2020 VS. 2021 (USD BILLION) 72
TABLE 4 NORTH AMERICA: PET HEALTH INSURANCE MARKET, 2012–2021 (USD MILLION) 72
5.2.1.3 Increasing number of veterinary practitioners in developed economies 73
TABLE 5 NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012–2020 73
FIGURE 30 US: DIAGNOSTIC SECTOR REVENUE GROWTH FROM 2014 TO 2019 74
FIGURE 31 US: DIAGNOSTIC SECTOR REVENUE GROWTH IN 2020 74
5.2.1.4 Increasing demand for animal-derived food products 75
TABLE 6 PAST AND PROJECTED TRENDS IN CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING COUNTRIES 75
TABLE 7 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 76
5.2.1.5 Increasing incidence of transboundary and zoonotic diseases 76
TABLE 8 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2019) 77
5.2.2 RESTRAINTS 78
5.2.2.1 Increasing pet care costs 78
FIGURE 32 US: BASIC ANNUAL EXPENSES FOR DOGS AND CATS, 2021 78
5.2.2.2 Growing demand for rapid tests, POC testing, and portable instruments 79
5.2.3 OPPORTUNITIES 79
5.2.3.1 Untapped emerging markets 79
5.2.3.2 Public-private partnerships in veterinary health 79
5.2.4 CHALLENGES 80
5.2.4.1 Low awareness in emerging markets 80
5.2.4.2 Shortage of veterinarians in emerging markets 80
TABLE 9 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY, 2005 VS. 2014 VS. 2018 81
5.2.4.3 Weak functional and infrastructural capacities 81
5.3 TECHNOLOGY ANALYSIS 82
5.3.1 DEVELOPMENT OF PORTABLE INSTRUMENTS FOR POC DIAGNOSTIC SERVICES 82
TABLE 10 LAUNCH OF POINT-OF-CARE PORTABLE VETERINARY DIAGNOSTIC TESTS 82
5.3.2 DEVELOPMENT OF RAPID AND SENSITIVE VETERINARY LABORATORY TESTS 82
5.4 INDUSTRY TRENDS 83
5.4.1 ADOPTION OF MULTIPLE TESTING PANELS 83
TABLE 11 MULTIPLE TESTING PANELS VS. SINGLE TESTING PANELS 83
5.4.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES 83
5.4.3 INNOVATION IN DIAGNOSTIC PRODUCTS FOR QUALITY SERVICE IMPLEMENTATION 83
TABLE 12 MAJOR PRODUCTS LAUNCHED FOR VETERINARY REFERENCE LABORATORIES AND VETERINARY HOSPITALS AND CLINICS 84
5.5 DISEASE TRENDS 84
5.5.1 LIVESTOCK ANIMALS 84
5.5.1.1 Avian Influenza (AI) 84
5.5.1.2 African Swine Fever (ASF) 84
5.5.1.3 Bovine Babesiosis (BB) 84
5.5.1.4 Peste des Petits Ruminants (PPR) 85
5.5.1.5 West Nile Virus (WNV) 85
5.5.2 COMPANION ANIMALS 85
5.5.2.1 Zoonotic diseases 85
TABLE 13 COMMON ZOONOTIC DISEASES SPREAD BY COMPANION ANIMALS 85
5.5.2.2 Obesity and diabetes 86
5.6 PRICING ANALYSIS 87
TABLE 14 PRICING ANALYSIS, 2019 VS. 2022 (USD) 87
5.7 ECOSYSTEM MAPPING 88
FIGURE 33 VETERINARY REFERENCE LABORATORY MARKET: ECOSYSTEM MARKET MAP 88
5.8 REGULATORY ANALYSIS 89
5.9 PATENT ANALYSIS 89
5.9.1 PATENT PUBLICATION TRENDS FOR VETERINARY REFERENCE LABORATORIES 89
FIGURE 34 GLOBAL PATENT PUBLICATION TRENDS IN VETERINARY REFERENCE LABORATORY MARKET, 2015–2022 89
5.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 90
FIGURE 35 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY REFERENCE LABORATORY PATENTS (JANUARY 2015–NOVEMBER 2022) 90
FIGURE 36 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY REFERENCE LABORATORY PATENTS (JANUARY 2015–NOVEMBER 2022) 91
5.10 IMPACT OF INFLATION AND RECESSION ON VETERINARY REFERENCE LABORATORY MARKET 91
6 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE 93
6.1 INTRODUCTION 94
TABLE 15 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 94
6.2 CLINICAL CHEMISTRY 94
6.2.1 GROWING PET HEALTHCARE EXPENDITURE TO DRIVE MARKET GROWTH 94
TABLE 16 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2020–2027 (USD MILLION) 95
6.3 IMMUNODIAGNOSTICS 95
TABLE 17 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 96
TABLE 18 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 97
6.3.1 ELISA 97
6.3.1.1 Advantages such as cost-effectiveness and ease of use to drive demand for ELISA tests 97
TABLE 19 ELISA TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 98
6.3.2 LATERAL FLOW ASSAYS 98
6.3.2.1 Lateral flow rapid tests to dominate market during forecast period 98
TABLE 20 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 99
6.3.3 OTHER IMMUNODIAGNOSTIC SERVICES 100
TABLE 21 OTHER IMMUNODIAGNOSTIC SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 100
6.4 MOLECULAR DIAGNOSTICS 101
TABLE 22 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 101
TABLE 23 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 102
6.4.1 PCR TESTS 102
6.4.1.1 Increased laboratory usage of PCR in proteomics and genomics to support growth 102
TABLE 24 PCR TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 103
6.4.2 MICROARRAYS 103
6.4.2.1 Growing applications of biochips in identification of infectious diseases to propel market 103
TABLE 25 MICROARRAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 104
6.4.3 OTHER MOLECULAR DIAGNOSTIC SERVICES 104
TABLE 26 OTHER MOLECULAR DIAGNOSTIC SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 105
6.5 HEMATOLOGY 105
6.5.1 GROWING NEED TO MEASURE BLOOD CELL COUNT AND COAGULATION TIME OF BLOOD IN ANIMALS TO DRIVE GROWTH 105
TABLE 27 VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 106
6.6 URINALYSIS 106
6.6.1 GROWING OCCURRENCE OF KIDNEY DISEASES IN CATS AND DOGS TO SUPPORT GROWTH 106
TABLE 28 VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY COUNTRY, 2020–2027 (USD MILLION) 107
6.7 OTHER SERVICES 108
TABLE 29 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES, BY COUNTRY, 2020–2027 (USD MILLION) 108

7 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION 109
7.1 INTRODUCTION 110
TABLE 30 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 110
7.2 CLINICAL PATHOLOGY 110
7.2.1 GOLD STANDARD FOR EVALUATION OF DISEASE PATTERNS TO DRIVE ADOPTION OF CLINICAL PATHOLOGY TESTS 110
TABLE 31 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL PATHOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 111
7.3 BACTERIOLOGY 111
7.3.1 RISING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE DEMAND FOR MICROBIOLOGICAL TESTS 111
TABLE 32 VETERINARY REFERENCE LABORATORY MARKET FOR BACTERIOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 112
7.4 VIROLOGY 112
7.4.1 GROWING NUMBER OF VIRAL OUTBREAKS TO CONTRIBUTE TO MARKET GROWTH 112
TABLE 33 VETERINARY REFERENCE LABORATORY MARKET FOR VIROLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 113
7.5 PARASITOLOGY 113
7.5.1 INCREASING PREVALENCE OF PARASITIC DISEASES TO SUPPORT GROWTH 113
TABLE 34 VETERINARY REFERENCE LABORATORY MARKET FOR PARASITOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 114
7.6 PRODUCTIVITY TESTING 114
7.6.1 GROWING FOCUS ON ENSURING QUALITY OF MILK AND MEAT TO DRIVE DEMAND FOR PRODUCTIVITY TESTING 114
TABLE 35 VETERINARY REFERENCE LABORATORY MARKET FOR PRODUCTIVITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 115
7.7 PREGNANCY TESTING 115
7.7.1 FOCUS ON BREEDING AND HERD MANAGEMENT PROGRAMS TO FUEL GROWTH 115
TABLE 36 VETERINARY REFERENCE LABORATORY MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 116
7.8 TOXICOLOGY TESTING 116
7.8.1 INCREASING REGULATIONS TO PREVENT FEED AND ANIMAL-DERIVED FOOD CONTAMINATION TO BOOST MARKET 116
TABLE 37 VETERINARY REFERENCE LABORATORY MARKET FOR TOXICOLOGY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 117
8 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE 118
8.1 INTRODUCTION 119
TABLE 38 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 119
8.2 COMPANION ANIMALS 119
TABLE 39 POPULATION OF SMALL COMPANION ANIMALS, BY COUNTRY, 2012–2021 (MILLION) 120
TABLE 40 VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 41 VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2020–2027 (USD MILLION) 121
8.2.1 DOGS 121
8.2.1.1 Increasing incidence of zoonotic diseases in dogs to drive growth 121
TABLE 42 NUMBER OF PET DOGS IN CHINA, 2013–2022 (MILLION) 122
TABLE 43 VETERINARY REFERENCE LABORATORY MARKET FOR DOGS, BY COUNTRY, 2020–2027 (USD MILLION) 122
8.2.2 CATS 123
8.2.2.1 Rising prevalence of infectious diseases in cats to support market 123
TABLE 44 NUMBER OF PET CATS IN CHINA, 2018–2022 (MILLION) 123
TABLE 45 VETERINARY REFERENCE LABORATORY MARKET FOR CATS, BY COUNTRY, 2020–2027 (USD MILLION) 124
8.2.3 HORSES 124
8.2.3.1 Reduced population growth rates of equines to limit market growth 124
TABLE 46 HORSE POPULATION, BY COUNTRY, 2012–2020 (THOUSAND) 125
TABLE 47 VETERINARY REFERENCE LABORATORY MARKET FOR HORSES, BY COUNTRY, 2020–2027 (USD MILLION) 125
8.2.4 OTHER COMPANION ANIMALS 126
TABLE 48 NUMBER OF PET-OWNING US HOUSEHOLDS, BY ANIMAL TYPE, 2019–2022 126
TABLE 49 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2020–2027 (USD MILLION) 127
8.3 LIVESTOCK ANIMALS 127
TABLE 50 VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 51 VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2020–2027 (USD MILLION) 129
8.3.1 CATTLE 129
8.3.1.1 Need to ensure herd healthcare to drive demand for cattle testing services 129
TABLE 52 CATTLE POPULATION, BY COUNTRY, 2012–2020 (MILLION) 130
TABLE 53 VETERINARY REFERENCE LABORATORY MARKET FOR CATTLE, BY COUNTRY, 2020–2027 (USD MILLION) 130
8.3.2 SWINE 131
8.3.2.1 Growing need to check disease outbreaks to drive growth 131
TABLE 54 SWINE POPULATION, BY COUNTRY, 2012–2020 (MILLION) 131
TABLE 55 VETERINARY REFERENCE LABORATORY MARKET FOR SWINE, BY COUNTRY, 2020–2027 (USD MILLION) 132
8.3.3 POULTRY 132
8.3.3.1 Growing demand for animal-derived protein sources from poultry to boost market 132
TABLE 56 POULTRY POPULATION, BY COUNTRY, 2012–2019 (MILLION) 133
TABLE 57 VETERINARY REFERENCE LABORATORY MARKET FOR POULTRY, BY COUNTRY, 2020–2027 (USD MILLION) 134
8.3.4 SHEEP & GOATS 134
8.3.4.1 Growing prevalence of diseases in sheep & goats to support growth 134
TABLE 58 SHEEP & GOAT POPULATION, BY COUNTRY, 2018–2020 (MILLION) 135
TABLE 59 VETERINARY REFERENCE LABORATORY MARKET FOR SHEEP & GOATS, BY COUNTRY, 2020–2027 (USD MILLION) 135
8.3.5 OTHER LIVESTOCK ANIMALS 136
TABLE 60 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2020–2027 (USD MILLION) 136
9 VETERINARY REFERENCE LABORATORY MARKET, BY REGION 137
9.1 INTRODUCTION 138
FIGURE 37 CHINA TO WITNESS HIGHEST GROWTH IN VETERINARY REFERENCE LABORATORY MARKET DURING FORECAST PERIOD 138
TABLE 61 VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 139
9.2 NORTH AMERICA 139
FIGURE 38 NORTH AMERICA: EXPECTED GROWTH IN NUMBER OF VETERINARIANS 140
FIGURE 39 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET SNAPSHOT 141
TABLE 62 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 141
TABLE 63 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 142
TABLE 64 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 65 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 66 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 143
TABLE 67 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 143
TABLE 68 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 69 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 144
9.2.1 US 144
9.2.1.1 US to dominate North American market during forecast period 144
FIGURE 40 US: POPULATION OF DOGS, 2012–2020 (MILLION) 145
FIGURE 41 US: EXPENDITURE ON VET VISITS, 2013–2020 145
TABLE 70 US: PRIVATE CLINICAL PRACTICES, BY ANIMAL TYPE, 2014–2021 146
TABLE 71 US: LARGE ANIMAL POPULATION, 2017–2020 (MILLION) 146
TABLE 72 US: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 146
TABLE 73 US: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 74 US: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 75 US: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 148
TABLE 76 US: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 148
TABLE 77 US: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 78 US: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 149
9.2.2 CANADA 149
9.2.2.1 Increasing population of livestock animals and adoption of pets to drive market 149
TABLE 79 CANADA: COMPANION ANIMAL POPULATION, 2016–2020 (MILLION) 150
TABLE 80 CANADA: LARGE ANIMAL POPULATION, 2001–2020 (MILLION) 150
TABLE 81 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 150
TABLE 82 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 83 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 84 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 152
TABLE 85 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 152
TABLE 86 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 87 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 153
9.3 EUROPE 154
TABLE 88 EUROPE: COMPANION ANIMAL POPULATION, 2021 (MILLION) 154
TABLE 89 EUROPE: LIVESTOCK POPULATION, 2020 (MILLION) 155
FIGURE 42 EUROPE: LIVESTOCK POPULATION, 2012–2019 (MILLION) 155
TABLE 90 EUROPE: NUMBER OF VETERINARIANS, 2012–2019 156
TABLE 91 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 156
TABLE 92 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 157
TABLE 93 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 94 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 95 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 96 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 158
TABLE 97 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 98 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 159
9.3.1 GERMANY 159
9.3.1.1 Growing collaborations between veterinary practices and reference laboratories to support growth 159
TABLE 99 GERMANY: COMPANION ANIMAL POPULATION, 2016–2021 (MILLION) 160
TABLE 100 GERMANY: NUMBER OF VETERINARIANS, 2014 VS. 2019 160
TABLE 101 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 161
TABLE 102 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 103 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 104 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 105 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 162
TABLE 106 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 107 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 163
9.3.2 UK 163
9.3.2.1 UK to account for second-largest market 163
TABLE 108 UK: PET POPULATION, 2017–2021 (MILLION) 164
TABLE 109 UK: LIVESTOCK POPULATION, 2016–2019 (MILLION) 164
TABLE 110 UK: NUMBER OF VETERINARIANS, 2014 VS. 2019 164
TABLE 111 UK: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 165
TABLE 112 UK: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 113 UK: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 114 UK: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 166
TABLE 115 UK: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 166
TABLE 116 UK: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 117 UK: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 167
9.3.3 FRANCE 167
9.3.3.1 Rising pet ownership rate to drive market 167
TABLE 118 FRANCE: COMPANION ANIMAL POPULATION, 2010–2021 (MILLION) 167
TABLE 119 FRANCE: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 168
TABLE 120 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 168
TABLE 121 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 122 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 123 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 170
TABLE 124 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 170
TABLE 125 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 170
TABLE 126 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 171
9.3.4 ITALY 171
9.3.4.1 Disease outbreaks and rising meat consumption to increase demand for testing facilities 171
TABLE 127 ITALY: PET POPULATION, 2017–2021 (MILLION) 171
TABLE 128 ITALY: LIVESTOCK POPULATION, 2016–2019 (MILLION) 172
TABLE 129 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 172
TABLE 130 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 131 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 173
TABLE 132 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 173
TABLE 133 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 173
TABLE 134 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 135 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 174
9.3.5 SPAIN 174
9.3.5.1 Increasing number of veterinary practices and willingness to spend on animal healthcare to propel market 174
TABLE 136 SPAIN: COMPANION ANIMAL POPULATION, 2016–2021 (MILLION) 175
TABLE 137 SPAIN: LIVESTOCK POPULATION, 2016–2020 (MILLION) 175
TABLE 138 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 176
TABLE 139 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 140 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 177
TABLE 141 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 177
TABLE 142 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 177
TABLE 143 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 144 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 178
9.3.6 REST OF EUROPE 178
TABLE 145 REST OF EUROPE: COMPANION ANIMAL OWNERSHIP, BY COUNTRY, 2021 (MILLION) 179
TABLE 146 REST OF EUROPE: LIVESTOCK ANIMAL POPULATION, BY COUNTRY, 2019 (MILLION) 179
TABLE 147 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 180
TABLE 148 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 180
TABLE 149 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 150 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 181
TABLE 151 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 181
TABLE 152 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 153 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 182
9.4 ASIA PACIFIC 182
FIGURE 43 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET SNAPSHOT 183
TABLE 154 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 184
TABLE 155 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 184
TABLE 156 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 157 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 158 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 186
TABLE 159 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 186
TABLE 160 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 187
TABLE 161 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 187
9.4.1 CHINA 187
9.4.1.1 Large pool of food-producing animals to drive market 187
TABLE 162 CHINA: LIVESTOCK POPULATION, 2010–2019 (MILLION) 188
TABLE 163 CHINA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 188
TABLE 164 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 189
TABLE 165 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 189
TABLE 166 CHINA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 190
TABLE 167 CHINA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 190
TABLE 168 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 169 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 191
9.4.2 JAPAN 191
9.4.2.1 Rising demand for diagnosing zoonotic diseases in imported pet breeds to drive market 191
TABLE 170 JAPAN: DOMESTICATED DOG AND CAT POPULATION, 2012–2020 (THOUSAND) 192
TABLE 171 JAPAN: PRODUCTION, CONSUMPTION, IMPORT, AND EXPORT OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS) 192
TABLE 172 JAPAN: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 193
TABLE 173 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 174 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 175 JAPAN: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 194
TABLE 176 JAPAN: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 194
TABLE 177 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 195
TABLE 178 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 195
9.4.3 INDIA 195
9.4.3.1 Increasing demand for livestock products to boost market 195
TABLE 179 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS) 196
TABLE 180 INDIA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 197
TABLE 181 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 197
TABLE 182 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 198
TABLE 183 INDIA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 198
TABLE 184 INDIA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 198
TABLE 185 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 199
TABLE 186 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 199
9.4.4 AUSTRALIA 199
9.4.4.1 Growing consumption of beef & mutton to propel market 199
TABLE 187 AUSTRALIA: LIVESTOCK POPULATION, BY COUNTRY, 2010–2019 (MILLION) 200
TABLE 188 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 200
TABLE 189 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 200
TABLE 190 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 191 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 201
TABLE 192 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 201
TABLE 193 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 202
TABLE 194 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 202
9.4.5 REST OF ASIA PACIFIC 202
TABLE 195 REST OF ASIA PACIFIC: LIVESTOCK POPULATION, BY COUNTRY, 2010–2019 (MILLION) 203
TABLE 196 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 204
TABLE 197 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 204
TABLE 198 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 204
TABLE 199 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 205
TABLE 200 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 205
TABLE 201 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 206
TABLE 202 REST OF ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 206

9.5 LATIN AMERICA 206
TABLE 203 LATIN AMERICA: LIVESTOCK POPULATION, BY COUNTRY, 2010–2019 (MILLION) 207
TABLE 204 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 207
TABLE 205 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 208
TABLE 206 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 208
TABLE 207 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 208
TABLE 208 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 209
TABLE 209 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 209
TABLE 210 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 211 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 210
9.5.1 BRAZIL 210
9.5.1.1 Well-established and rapidly growing livestock industry to propel market 210
TABLE 212 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 211
TABLE 213 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 211
TABLE 214 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 212
TABLE 215 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 212
TABLE 216 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 212
TABLE 217 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 213
TABLE 218 BRAZIL: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 213
9.5.2 MEXICO 213
9.5.2.1 Willingness of pet owners to spend on pet health to fuel growth 213
TABLE 219 MEXICO: LIVESTOCK POPULATION, 2010–2019 (MILLION) 214
TABLE 220 MEXICO: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 214
TABLE 221 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 214
TABLE 222 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 215
TABLE 223 MEXICO: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 215
TABLE 224 MEXICO: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 215
TABLE 225 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 216
TABLE 226 MEXICO: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 216
9.5.3 REST OF LATIN AMERICA 216
TABLE 227 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 217
TABLE 228 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 217
TABLE 229 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 218
TABLE 230 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 218
TABLE 231 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 218
TABLE 232 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 219
TABLE 233 REST OF LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 219
9.6 MIDDLE EAST & AFRICA 220
9.6.1 LOW PORK PRODUCTION AND CONSUMPTION DUE TO RELIGIOUS CUSTOMS TO LIMIT GROWTH 220
TABLE 234 MIDDLE EAST: LIVESTOCK POPULATION, 2010 VS. 2019 (MILLION) 220
TABLE 235 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION) 221
TABLE 236 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 221
TABLE 237 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION) 222
TABLE 238 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 222
TABLE 239 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 222
TABLE 240 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 223
TABLE 241 MIDDLE EAST & AFRICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 223
10 COMPETITIVE LANDSCAPE 224
10.1 INTRODUCTION 224
FIGURE 44 KEY MARKET DEVELOPMENTS (JANUARY 2019 TO NOVEMBER 2022) 224
10.2 REVENUE ANALYSIS OF KEY MARKET PLAYERS 225
FIGURE 45 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN VETERINARY REFERENCE LABORATORY MARKET 225
10.3 MARKET SHARE ANALYSIS (2021) 226
FIGURE 46 VETERINARY REFERENCE LABORATORY MARKET SHARE,
BY KEY PLAYER, 2021 226
10.4 COMPETITIVE BENCHMARKING 227
10.4.1 OVERALL COMPANY FOOTPRINT 227
10.4.2 COMPANY FOOTPRINT, BY SERVICE 228
10.4.3 COMPANY FOOTPRINT, BY APPLICATION 230
10.4.4 COMPANY FOOTPRINT, BY ANIMAL TYPE 231
10.4.5 COMPANY FOOTPRINT, BY REGION 232
10.5 VETERINARY REFERENCE LABORATORY MARKET: R&D EXPENDITURE 234
FIGURE 47 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET (2020 VS. 2021) 234
10.6 COMPANY EVALUATION QUADRANT 234
10.6.1 STARS 234
10.6.2 EMERGING LEADERS 234
10.6.3 PERVASIVE PLAYERS 235
10.6.4 PARTICIPANTS 235
FIGURE 48 VETERINARY REFERENCE LABORATORY MARKET:
COMPANY EVALUATION QUADRANT 235
10.7 COMPANY EVALUATION QUADRANT FOR SMES/START-UPS 236
10.7.1 PROGRESSIVE COMPANIES 236
10.7.2 STARTING BLOCKS 236
10.7.3 RESPONSIVE COMPANIES 236
10.7.4 DYNAMIC COMPANIES 236
FIGURE 49 VETERINARY REFERENCE LABORATORY MARKET:
COMPANY EVALUATION QUADRANT FOR SMES/START-UPS 237
10.8 COMPETITIVE SCENARIO 238
10.8.1 SERVICE LAUNCHES 238
TABLE 242 VETERINARY REFERENCE LABORATORY MARKET:
SERVICE LAUNCHES (JANUARY 2019 TO NOVEMBER 2022) 238
10.8.2 DEALS 239
TABLE 243 VETERINARY REFERENCE LABORATORY MARKET:
DEALS (JANUARY 2019 TO NOVEMBER 2022) 239
11 COMPANY PROFILES 240
(Business Overview, Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1 KEY PLAYERS 240
11.1.1 IDEXX LABORATORIES 240
TABLE 244 IDEXX LABORATORIES: BUSINESS OVERVIEW 240
FIGURE 50 IDEXX LABORATORIES: COMPANY SNAPSHOT (2021) 241
11.1.2 VCA 247
TABLE 245 VCA: BUSINESS OVERVIEW 247
11.1.3 GD ANIMAL HEALTH 249
TABLE 246 GD ANIMAL HEALTH: BUSINESS OVERVIEW 249
11.1.4 ZOETIS 256
TABLE 247 ZOETIS: BUSINESS OVERVIEW 256
FIGURE 51 ZOETIS: COMPANY SNAPSHOT (2021) 257
11.1.5 NEOGEN CORPORATION 263
TABLE 248 NEOGEN CORPORATION: BUSINESS OVERVIEW 263
FIGURE 52 NEOGEN CORPORATION: COMPANY SNAPSHOT (2021) 264
11.1.6 LABOKLIN 269
TABLE 249 LABOKLIN: BUSINESS OVERVIEW 269
11.1.7 SYNLAB INTERNATIONAL 272
TABLE 250 SYNLAB INTERNATIONAL: BUSINESS OVERVIEW 272
11.1.8 HESKA CORPORATION 276
TABLE 251 HESKA CORPORATION: BUSINESS OVERVIEW 276
FIGURE 53 HESKA CORPORATION: COMPANY SNAPSHOT (2021) 277
11.1.9 VIRBAC 280
TABLE 252 VIRBAC: BUSINESS OVERVIEW 280
FIGURE 54 VIRBAC: COMPANY SNAPSHOT (2021) 281
11.1.10 THERMO FISHER SCIENTIFIC 282
TABLE 253 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 282
FIGURE 55 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021) 283
11.2 OTHER PLAYERS 285
11.2.1 VAXXINOVA 285
TABLE 254 VAXXINOVA: BUSINESS OVERVIEW 285
11.2.2 TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY 288
TABLE 255 TVMDL: BUSINESS OVERVIEW 288
11.2.3 UNIVERSITY OF MINNESOTA (VETERINARY DIAGNOSTIC LABORATORY) 290
TABLE 256 UNIVERSITY OF MINNESOTA VETERINARY DIAGNOSTIC LABORATORY: BUSINESS OVERVIEW 290
11.2.4 IOWA STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY) 292
TABLE 257 IOWA STATE UNIVERSITY VETERINARY DIAGNOSTIC LABORATORY:
BUSINESS OVERVIEW 292
11.2.5 VETNOSTICS 293
TABLE 258 VETNOSTICS: BUSINESS OVERVIEW 293
11.2.6 GREENCROSS LIMITED 294
TABLE 259 GREENCROSS LIMITED: BUSINESS OVERVIEW 294
11.2.7 PROTATEK INTERNATIONAL 295
TABLE 260 PROTATEK INTERNATIONAL: BUSINESS OVERVIEW 295
11.2.8 ANIMAL AND PLANT HEALTH AGENCY 296
TABLE 261 ANIMAL AND PLANT HEALTH AGENCY: BUSINESS OVERVIEW 296
11.2.9 ANIMAL HEALTH DIAGNOSTIC CENTER (CORNELL UNIVERSITY) 297
TABLE 262 ANIMAL HEALTH DIAGNOSTIC CENTER (CORNELL UNIVERSITY):
BUSINESS OVERVIEW 297
11.2.10 NATIONAL VETERINARY SERVICES LABORATORY USDA APHIS 298
TABLE 263 NATIONAL VETERINARY SERVICES LABORATORY USDA-APHIS:
BUSINESS OVERVIEW 298
11.2.11 WASHINGTON ANIMAL DISEASE DIAGNOSTIC LABORATORY (WADDL) 299
TABLE 264 WASHINGTON ANIMAL DISEASE DIAGNOSTIC LABORATORY (WADDL): BUSINESS OVERVIEW 299
11.2.12 COLORADO STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORIES) 300
TABLE 265 COLORADO STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY): BUSINESS OVERVIEW 300
11.2.13 THE PIRBRIGHT INSTITUTE 301
TABLE 266 THE PIRBRIGHT INSTITUTE: BUSINESS OVERVIEW 301
11.2.14 FRIEDRICH-LOEFFLER-INSTITUT (FLI) 302
TABLE 267 THE FRIEDRICH-LOEFFLER-INSTITUT (FLI): BUSINESS OVERVIEW 302
11.2.15 KANSAS STATE VETERINARY DIAGNOSTIC LABORATORY 303
TABLE 268 KANSAS STATE VETERINARY DIAGNOSTIC LABORATORY:
BUSINESS OVERVIEW 303
 
12 APPENDIX 304
12.1 DISCUSSION GUIDE 304
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 311
12.3 CUSTOMIZATION OPTIONS 313
12.4 RELATED REPORTS 313
12.5 AUTHOR DETAILS 314

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 衛星IoTの世界市場予測（～2027）：サービス種類別、周波数帯別、組織規模別、産業別、地域別
  • バッテリー交換の世界市場予測（～2027）：ステーション種類別、サービス種類別、用途別、バッテリー容量別、車種別、用途別、地域別
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MD4362-23 )"動物用レファレンスラボラトリーの世界市場予測（～2027）：サービス種類別、用途別、動物別、地域別" (英文：Veterinary Reference Laboratory Market by Service Type (Clinical Chemistry, Immunodiagnostics (ELISA), Molecular Diagnostics (PCR, Microarray)), Application (Pathology, Virology), Animal (Companion, Livestock), and Region - Global Forecast to 2027)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。